Global Transdermal Skin Patch Market Growth 2025-2031

January 2025 | 118 pages | ID: GF858324C678EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global Transdermal Skin Patch market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Transdermal Skin Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Transdermal Skin Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Transdermal Skin Patch is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Transdermal Skin Patch players cover Hisamitsu Pharmaceutical, Novartis, Johnson & Johnson, Teikoku Pharma, Mylan, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Transdermal Skin Patch Industry Forecast” looks at past sales and reviews total world Transdermal Skin Patch sales in 2024, providing a comprehensive analysis by region and market sector of projected Transdermal Skin Patch sales for 2025 through 2031. With Transdermal Skin Patch sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transdermal Skin Patch industry.

This Insight Report provides a comprehensive analysis of the global Transdermal Skin Patch landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transdermal Skin Patch portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transdermal Skin Patch market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transdermal Skin Patch and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transdermal Skin Patch.

This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Skin Patch market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

• Fentanyl Transdermal Skin Patch
• Nicotine Transdermal Skin Patch
• Clonidine Transdermal Skin Patch
• Buprenorphine Transdermal Skin Patch

Segmentation by Application:

• Relieve Severe Pain
• Stop Smoking Cigarettes
• Treat an Overactive Bladder
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

• Hisamitsu Pharmaceutical
• Novartis
• Johnson & Johnson
• Teikoku Pharma
• Mylan
• Actavis
• Mundipharma
• Henan Lingrui Pharmaceutical
• Changzhou Siyao
• Rfl Pharmaceutical
• Luye Pharma Group Ltd.
• Purdue Pharma L.P.
• Teva Pharmaceutical Industries Ltd.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Transdermal Skin Patch market?

What factors are driving Transdermal Skin Patch market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Transdermal Skin Patch market opportunities vary by end market size?

How does Transdermal Skin Patch break out by Type, by Application?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Transdermal Skin Patch Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Transdermal Skin Patch by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Transdermal Skin Patch by Country/Region, 2020, 2024 & 2031
2.2 Transdermal Skin Patch Segment by Type
  2.2.1 Fentanyl Transdermal Skin Patch
  2.2.2 Nicotine Transdermal Skin Patch
  2.2.3 Clonidine Transdermal Skin Patch
  2.2.4 Buprenorphine Transdermal Skin Patch
2.3 Transdermal Skin Patch Sales by Type
  2.3.1 Global Transdermal Skin Patch Sales Market Share by Type (2020-2025)
  2.3.2 Global Transdermal Skin Patch Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Transdermal Skin Patch Sale Price by Type (2020-2025)
2.4 Transdermal Skin Patch Segment by Application
  2.4.1 Relieve Severe Pain
  2.4.2 Stop Smoking Cigarettes
  2.4.3 Treat an Overactive Bladder
  2.4.4 Others
2.5 Transdermal Skin Patch Sales by Application
  2.5.1 Global Transdermal Skin Patch Sale Market Share by Application (2020-2025)
  2.5.2 Global Transdermal Skin Patch Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Transdermal Skin Patch Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Transdermal Skin Patch Breakdown Data by Company
  3.1.1 Global Transdermal Skin Patch Annual Sales by Company (2020-2025)
  3.1.2 Global Transdermal Skin Patch Sales Market Share by Company (2020-2025)
3.2 Global Transdermal Skin Patch Annual Revenue by Company (2020-2025)
  3.2.1 Global Transdermal Skin Patch Revenue by Company (2020-2025)
  3.2.2 Global Transdermal Skin Patch Revenue Market Share by Company (2020-2025)
3.3 Global Transdermal Skin Patch Sale Price by Company
3.4 Key Manufacturers Transdermal Skin Patch Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Transdermal Skin Patch Product Location Distribution
  3.4.2 Players Transdermal Skin Patch Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR TRANSDERMAL SKIN PATCH BY GEOGRAPHIC REGION

4.1 World Historic Transdermal Skin Patch Market Size by Geographic Region (2020-2025)
  4.1.1 Global Transdermal Skin Patch Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Transdermal Skin Patch Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Transdermal Skin Patch Market Size by Country/Region (2020-2025)
  4.2.1 Global Transdermal Skin Patch Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Transdermal Skin Patch Annual Revenue by Country/Region (2020-2025)
4.3 Americas Transdermal Skin Patch Sales Growth
4.4 APAC Transdermal Skin Patch Sales Growth
4.5 Europe Transdermal Skin Patch Sales Growth
4.6 Middle East & Africa Transdermal Skin Patch Sales Growth

5 AMERICAS

5.1 Americas Transdermal Skin Patch Sales by Country
  5.1.1 Americas Transdermal Skin Patch Sales by Country (2020-2025)
  5.1.2 Americas Transdermal Skin Patch Revenue by Country (2020-2025)
5.2 Americas Transdermal Skin Patch Sales by Type (2020-2025)
5.3 Americas Transdermal Skin Patch Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Transdermal Skin Patch Sales by Region
  6.1.1 APAC Transdermal Skin Patch Sales by Region (2020-2025)
  6.1.2 APAC Transdermal Skin Patch Revenue by Region (2020-2025)
6.2 APAC Transdermal Skin Patch Sales by Type (2020-2025)
6.3 APAC Transdermal Skin Patch Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Transdermal Skin Patch by Country
  7.1.1 Europe Transdermal Skin Patch Sales by Country (2020-2025)
  7.1.2 Europe Transdermal Skin Patch Revenue by Country (2020-2025)
7.2 Europe Transdermal Skin Patch Sales by Type (2020-2025)
7.3 Europe Transdermal Skin Patch Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Transdermal Skin Patch by Country
  8.1.1 Middle East & Africa Transdermal Skin Patch Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Transdermal Skin Patch Revenue by Country (2020-2025)
8.2 Middle East & Africa Transdermal Skin Patch Sales by Type (2020-2025)
8.3 Middle East & Africa Transdermal Skin Patch Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Transdermal Skin Patch
10.3 Manufacturing Process Analysis of Transdermal Skin Patch
10.4 Industry Chain Structure of Transdermal Skin Patch

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Transdermal Skin Patch Distributors
11.3 Transdermal Skin Patch Customer

12 WORLD FORECAST REVIEW FOR TRANSDERMAL SKIN PATCH BY GEOGRAPHIC REGION

12.1 Global Transdermal Skin Patch Market Size Forecast by Region
  12.1.1 Global Transdermal Skin Patch Forecast by Region (2026-2031)
  12.1.2 Global Transdermal Skin Patch Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Transdermal Skin Patch Forecast by Type (2026-2031)
12.7 Global Transdermal Skin Patch Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Hisamitsu Pharmaceutical
  13.1.1 Hisamitsu Pharmaceutical Company Information
  13.1.2 Hisamitsu Pharmaceutical Transdermal Skin Patch Product Portfolios and Specifications
  13.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Hisamitsu Pharmaceutical Main Business Overview
  13.1.5 Hisamitsu Pharmaceutical Latest Developments
13.2 Novartis
  13.2.1 Novartis Company Information
  13.2.2 Novartis Transdermal Skin Patch Product Portfolios and Specifications
  13.2.3 Novartis Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Novartis Main Business Overview
  13.2.5 Novartis Latest Developments
13.3 Johnson & Johnson
  13.3.1 Johnson & Johnson Company Information
  13.3.2 Johnson & Johnson Transdermal Skin Patch Product Portfolios and Specifications
  13.3.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Johnson & Johnson Main Business Overview
  13.3.5 Johnson & Johnson Latest Developments
13.4 Teikoku Pharma
  13.4.1 Teikoku Pharma Company Information
  13.4.2 Teikoku Pharma Transdermal Skin Patch Product Portfolios and Specifications
  13.4.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 Teikoku Pharma Main Business Overview
  13.4.5 Teikoku Pharma Latest Developments
13.5 Mylan
  13.5.1 Mylan Company Information
  13.5.2 Mylan Transdermal Skin Patch Product Portfolios and Specifications
  13.5.3 Mylan Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Mylan Main Business Overview
  13.5.5 Mylan Latest Developments
13.6 Actavis
  13.6.1 Actavis Company Information
  13.6.2 Actavis Transdermal Skin Patch Product Portfolios and Specifications
  13.6.3 Actavis Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Actavis Main Business Overview
  13.6.5 Actavis Latest Developments
13.7 Mundipharma
  13.7.1 Mundipharma Company Information
  13.7.2 Mundipharma Transdermal Skin Patch Product Portfolios and Specifications
  13.7.3 Mundipharma Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Mundipharma Main Business Overview
  13.7.5 Mundipharma Latest Developments
13.8 Henan Lingrui Pharmaceutical
  13.8.1 Henan Lingrui Pharmaceutical Company Information
  13.8.2 Henan Lingrui Pharmaceutical Transdermal Skin Patch Product Portfolios and Specifications
  13.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Henan Lingrui Pharmaceutical Main Business Overview
  13.8.5 Henan Lingrui Pharmaceutical Latest Developments
13.9 Changzhou Siyao
  13.9.1 Changzhou Siyao Company Information
  13.9.2 Changzhou Siyao Transdermal Skin Patch Product Portfolios and Specifications
  13.9.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Changzhou Siyao Main Business Overview
  13.9.5 Changzhou Siyao Latest Developments
13.10 Rfl Pharmaceutical
  13.10.1 Rfl Pharmaceutical Company Information
  13.10.2 Rfl Pharmaceutical Transdermal Skin Patch Product Portfolios and Specifications
  13.10.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Rfl Pharmaceutical Main Business Overview
  13.10.5 Rfl Pharmaceutical Latest Developments
13.11 Luye Pharma Group Ltd.
  13.11.1 Luye Pharma Group Ltd. Company Information
  13.11.2 Luye Pharma Group Ltd. Transdermal Skin Patch Product Portfolios and Specifications
  13.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Luye Pharma Group Ltd. Main Business Overview
  13.11.5 Luye Pharma Group Ltd. Latest Developments
13.12 Purdue Pharma L.P.
  13.12.1 Purdue Pharma L.P. Company Information
  13.12.2 Purdue Pharma L.P. Transdermal Skin Patch Product Portfolios and Specifications
  13.12.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Purdue Pharma L.P. Main Business Overview
  13.12.5 Purdue Pharma L.P. Latest Developments
13.13 Teva Pharmaceutical Industries Ltd.
  13.13.1 Teva Pharmaceutical Industries Ltd. Company Information
  13.13.2 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Product Portfolios and Specifications
  13.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
  13.13.5 Teva Pharmaceutical Industries Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OFTABLES

Table 1.Transdermal Skin Patch Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2.Transdermal Skin Patch Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players ofFentanylTransdermal Skin Patch
Table 4. Major Players of NicotineTransdermal Skin Patch
Table 5. Major Players of ClonidineTransdermal Skin Patch
Table 6. Major Players of BuprenorphineTransdermal Skin Patch
Table 7. GlobalTransdermal Skin Patch Sales byType (2020-2025) & (K Units)
Table 8. GlobalTransdermal Skin Patch Sales Market Share byType (2020-2025)
Table 9. GlobalTransdermal Skin Patch Revenue byType (2020-2025) & ($ million)
Table 10. GlobalTransdermal Skin Patch Revenue Market Share byType (2020-2025)
Table 11. GlobalTransdermal Skin Patch Sale Price byType (2020-2025) & (USD/Unit)
Table 12. GlobalTransdermal Skin Patch Sale by Application (2020-2025) & (K Units)
Table 13. GlobalTransdermal Skin Patch Sale Market Share by Application (2020-2025)
Table 14. GlobalTransdermal Skin Patch Revenue by Application (2020-2025) & ($ million)
Table 15. GlobalTransdermal Skin Patch Revenue Market Share by Application (2020-2025)
Table 16. GlobalTransdermal Skin Patch Sale Price by Application (2020-2025) & (USD/Unit)
Table 17. GlobalTransdermal Skin Patch Sales by Company (2020-2025) & (K Units)
Table 18. GlobalTransdermal Skin Patch Sales Market Share by Company (2020-2025)
Table 19. GlobalTransdermal Skin Patch Revenue by Company (2020-2025) & ($ millions)
Table 20. GlobalTransdermal Skin Patch Revenue Market Share by Company (2020-2025)
Table 21. GlobalTransdermal Skin Patch Sale Price by Company (2020-2025) & (USD/Unit)
Table 22. Key ManufacturersTransdermal Skin Patch Producing Area Distribution and Sales Area
Table 23. PlayersTransdermal Skin Patch Products Offered
Table 24.Transdermal Skin Patch Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. GlobalTransdermal Skin Patch Sales by Geographic Region (2020-2025) & (K Units)
Table 28. GlobalTransdermal Skin Patch Sales Market Share Geographic Region (2020-2025)
Table 29. GlobalTransdermal Skin Patch Revenue by Geographic Region (2020-2025) & ($ millions)
Table 30. GlobalTransdermal Skin Patch Revenue Market Share by Geographic Region (2020-2025)
Table 31. GlobalTransdermal Skin Patch Sales by Country/Region (2020-2025) & (K Units)
Table 32. GlobalTransdermal Skin Patch Sales Market Share by Country/Region (2020-2025)
Table 33. GlobalTransdermal Skin Patch Revenue by Country/Region (2020-2025) & ($ millions)
Table 34. GlobalTransdermal Skin Patch Revenue Market Share by Country/Region (2020-2025)
Table 35. AmericasTransdermal Skin Patch Sales by Country (2020-2025) & (K Units)
Table 36. AmericasTransdermal Skin Patch Sales Market Share by Country (2020-2025)
Table 37. AmericasTransdermal Skin Patch Revenue by Country (2020-2025) & ($ millions)
Table 38. AmericasTransdermal Skin Patch Sales byType (2020-2025) & (K Units)
Table 39. AmericasTransdermal Skin Patch Sales by Application (2020-2025) & (K Units)
Table 40. APACTransdermal Skin Patch Sales by Region (2020-2025) & (K Units)
Table 41. APACTransdermal Skin Patch Sales Market Share by Region (2020-2025)
Table 42. APACTransdermal Skin Patch Revenue by Region (2020-2025) & ($ millions)
Table 43. APACTransdermal Skin Patch Sales byType (2020-2025) & (K Units)
Table 44. APACTransdermal Skin Patch Sales by Application (2020-2025) & (K Units)
Table 45. EuropeTransdermal Skin Patch Sales by Country (2020-2025) & (K Units)
Table 46. EuropeTransdermal Skin Patch Revenue by Country (2020-2025) & ($ millions)
Table 47. EuropeTransdermal Skin Patch Sales byType (2020-2025) & (K Units)
Table 48. EuropeTransdermal Skin Patch Sales by Application (2020-2025) & (K Units)
Table 49. Middle East & AfricaTransdermal Skin Patch Sales by Country (2020-2025) & (K Units)
Table 50. Middle East & AfricaTransdermal Skin Patch Revenue Market Share by Country (2020-2025)
Table 51. Middle East & AfricaTransdermal Skin Patch Sales byType (2020-2025) & (K Units)
Table 52. Middle East & AfricaTransdermal Skin Patch Sales by Application (2020-2025) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities ofTransdermal Skin Patch
Table 54. Key Market Challenges & Risks ofTransdermal Skin Patch
Table 55. Key IndustryTrends ofTransdermal Skin Patch
Table 56.Transdermal Skin Patch Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58.Transdermal Skin Patch Distributors List
Table 59.Transdermal Skin Patch Customer List
Table 60. GlobalTransdermal Skin Patch SalesForecast by Region (2026-2031) & (K Units)
Table 61. GlobalTransdermal Skin Patch RevenueForecast by Region (2026-2031) & ($ millions)
Table 62. AmericasTransdermal Skin Patch SalesForecast by Country (2026-2031) & (K Units)
Table 63. AmericasTransdermal Skin Patch Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 64. APACTransdermal Skin Patch SalesForecast by Region (2026-2031) & (K Units)
Table 65. APACTransdermal Skin Patch Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 66. EuropeTransdermal Skin Patch SalesForecast by Country (2026-2031) & (K Units)
Table 67. EuropeTransdermal Skin Patch RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Middle East & AfricaTransdermal Skin Patch SalesForecast by Country (2026-2031) & (K Units)
Table 69. Middle East & AfricaTransdermal Skin Patch RevenueForecast by Country (2026-2031) & ($ millions)
Table 70. GlobalTransdermal Skin Patch SalesForecast byType (2026-2031) & (K Units)
Table 71. GlobalTransdermal Skin Patch RevenueForecast byType (2026-2031) & ($ millions)
Table 72. GlobalTransdermal Skin Patch SalesForecast by Application (2026-2031) & (K Units)
Table 73. GlobalTransdermal Skin Patch RevenueForecast by Application (2026-2031) & ($ millions)
Table 74. Hisamitsu Pharmaceutical Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 75. Hisamitsu PharmaceuticalTransdermal Skin Patch Product Portfolios and Specifications
Table 76. Hisamitsu PharmaceuticalTransdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Hisamitsu Pharmaceutical Main Business
Table 78. Hisamitsu Pharmaceutical Latest Developments
Table 79. Novartis Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 80. NovartisTransdermal Skin Patch Product Portfolios and Specifications
Table 81. NovartisTransdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Novartis Main Business
Table 83. Novartis Latest Developments
Table 84. Johnson & Johnson Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 85. Johnson & JohnsonTransdermal Skin Patch Product Portfolios and Specifications
Table 86. Johnson & JohnsonTransdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Johnson & Johnson Main Business
Table 88. Johnson & Johnson Latest Developments
Table 89.Teikoku Pharma Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 90.Teikoku PharmaTransdermal Skin Patch Product Portfolios and Specifications
Table 91.Teikoku PharmaTransdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92.Teikoku Pharma Main Business
Table 93.Teikoku Pharma Latest Developments
Table 94. Mylan Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 95. MylanTransdermal Skin Patch Product Portfolios and Specifications
Table 96. MylanTransdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Mylan Main Business
Table 98. Mylan Latest Developments
Table 99. Actavis Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 100. ActavisTransdermal Skin Patch Product Portfolios and Specifications
Table 101. ActavisTransdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Actavis Main Business
Table 103. Actavis Latest Developments
Table 104. Mundipharma Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 105. MundipharmaTransdermal Skin Patch Product Portfolios and Specifications
Table 106. MundipharmaTransdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Mundipharma Main Business
Table 108. Mundipharma Latest Developments
Table 109. Henan Lingrui Pharmaceutical Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 110. Henan Lingrui PharmaceuticalTransdermal Skin Patch Product Portfolios and Specifications
Table 111. Henan Lingrui PharmaceuticalTransdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Henan Lingrui Pharmaceutical Main Business
Table 113. Henan Lingrui Pharmaceutical Latest Developments
Table 114. Changzhou Siyao Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 115. Changzhou SiyaoTransdermal Skin Patch Product Portfolios and Specifications
Table 116. Changzhou SiyaoTransdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Changzhou Siyao Main Business
Table 118. Changzhou Siyao Latest Developments
Table 119. Rfl Pharmaceutical Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 120. Rfl PharmaceuticalTransdermal Skin Patch Product Portfolios and Specifications
Table 121. Rfl PharmaceuticalTransdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Rfl Pharmaceutical Main Business
Table 123. Rfl Pharmaceutical Latest Developments
Table 124. Luye Pharma Group Ltd. Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 125. Luye Pharma Group Ltd.Transdermal Skin Patch Product Portfolios and Specifications
Table 126. Luye Pharma Group Ltd.Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Luye Pharma Group Ltd. Main Business
Table 128. Luye Pharma Group Ltd. Latest Developments
Table 129. Purdue Pharma L.P. Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 130. Purdue Pharma L.P.Transdermal Skin Patch Product Portfolios and Specifications
Table 131. Purdue Pharma L.P.Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Purdue Pharma L.P. Main Business
Table 133. Purdue Pharma L.P. Latest Developments
Table 134.Teva Pharmaceutical Industries Ltd. Basic Information,Transdermal Skin Patch Manufacturing Base, Sales Area and Its Competitors
Table 135.Teva Pharmaceutical Industries Ltd.Transdermal Skin Patch Product Portfolios and Specifications
Table 136.Teva Pharmaceutical Industries Ltd.Transdermal Skin Patch Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137.Teva Pharmaceutical Industries Ltd. Main Business
Table 138.Teva Pharmaceutical Industries Ltd. Latest Developments



LIST OFFIGURES

Figure 1. Picture ofTransdermal Skin Patch
Figure 2.Transdermal Skin Patch Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. GlobalTransdermal Skin Patch Sales Growth Rate 2020-2031 (K Units)
Figure 7. GlobalTransdermal Skin Patch Revenue Growth Rate 2020-2031 ($ millions)
Figure 8.Transdermal Skin Patch Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9.Transdermal Skin Patch Sales Market Share by Country/Region (2024)
Figure 10.Transdermal Skin Patch Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture ofFentanylTransdermal Skin Patch
Figure 12. Product Picture of NicotineTransdermal Skin Patch
Figure 13. Product Picture of ClonidineTransdermal Skin Patch
Figure 14. Product Picture of BuprenorphineTransdermal Skin Patch
Figure 15. GlobalTransdermal Skin Patch Sales Market Share byType in 2025
Figure 16. GlobalTransdermal Skin Patch Revenue Market Share byType (2020-2025)
Figure 17.Transdermal Skin Patch Consumed in Relieve Severe Pain
Figure 18. GlobalTransdermal Skin Patch Market: Relieve Severe Pain (2020-2025) & (K Units)
Figure 19.Transdermal Skin Patch Consumed in Stop Smoking Cigarettes
Figure 20. GlobalTransdermal Skin Patch Market: Stop Smoking Cigarettes (2020-2025) & (K Units)
Figure 21.Transdermal Skin Patch Consumed inTreat an Overactive Bladder
Figure 22. GlobalTransdermal Skin Patch Market:Treat an Overactive Bladder (2020-2025) & (K Units)
Figure 23.Transdermal Skin Patch Consumed in Others
Figure 24. GlobalTransdermal Skin Patch Market: Others (2020-2025) & (K Units)
Figure 25. GlobalTransdermal Skin Patch Sale Market Share by Application (2024)
Figure 26. GlobalTransdermal Skin Patch Revenue Market Share by Application in 2025
Figure 27.Transdermal Skin Patch Sales by Company in 2025 (K Units)
Figure 28. GlobalTransdermal Skin Patch Sales Market Share by Company in 2025
Figure 29.Transdermal Skin Patch Revenue by Company in 2025 ($ millions)
Figure 30. GlobalTransdermal Skin Patch Revenue Market Share by Company in 2025
Figure 31. GlobalTransdermal Skin Patch Sales Market Share by Geographic Region (2020-2025)
Figure 32. GlobalTransdermal Skin Patch Revenue Market Share by Geographic Region in 2025
Figure 33. AmericasTransdermal Skin Patch Sales 2020-2025 (K Units)
Figure 34. AmericasTransdermal Skin Patch Revenue 2020-2025 ($ millions)
Figure 35. APACTransdermal Skin Patch Sales 2020-2025 (K Units)
Figure 36. APACTransdermal Skin Patch Revenue 2020-2025 ($ millions)
Figure 37. EuropeTransdermal Skin Patch Sales 2020-2025 (K Units)
Figure 38. EuropeTransdermal Skin Patch Revenue 2020-2025 ($ millions)
Figure 39. Middle East & AfricaTransdermal Skin Patch Sales 2020-2025 (K Units)
Figure 40. Middle East & AfricaTransdermal Skin Patch Revenue 2020-2025 ($ millions)
Figure 41. AmericasTransdermal Skin Patch Sales Market Share by Country in 2025
Figure 42. AmericasTransdermal Skin Patch Revenue Market Share by Country (2020-2025)
Figure 43. AmericasTransdermal Skin Patch Sales Market Share byType (2020-2025)
Figure 44. AmericasTransdermal Skin Patch Sales Market Share by Application (2020-2025)
Figure 45. United StatesTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 46. CanadaTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 47. MexicoTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 48. BrazilTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 49. APACTransdermal Skin Patch Sales Market Share by Region in 2025
Figure 50. APACTransdermal Skin Patch Revenue Market Share by Region (2020-2025)
Figure 51. APACTransdermal Skin Patch Sales Market Share byType (2020-2025)
Figure 52. APACTransdermal Skin Patch Sales Market Share by Application (2020-2025)
Figure 53. ChinaTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 54. JapanTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 55. South KoreaTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 56. Southeast AsiaTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 57. IndiaTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 58. AustraliaTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 59. ChinaTaiwanTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 60. EuropeTransdermal Skin Patch Sales Market Share by Country in 2025
Figure 61. EuropeTransdermal Skin Patch Revenue Market Share by Country (2020-2025)
Figure 62. EuropeTransdermal Skin Patch Sales Market Share byType (2020-2025)
Figure 63. EuropeTransdermal Skin Patch Sales Market Share by Application (2020-2025)
Figure 64. GermanyTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 65.FranceTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 66. UKTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 67. ItalyTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 68. RussiaTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 69. Middle East & AfricaTransdermal Skin Patch Sales Market Share by Country (2020-2025)
Figure 70. Middle East & AfricaTransdermal Skin Patch Sales Market Share byType (2020-2025)
Figure 71. Middle East & AfricaTransdermal Skin Patch Sales Market Share by Application (2020-2025)
Figure 72. EgyptTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 73. South AfricaTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 74. IsraelTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 75.TurkeyTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 76. GCC CountriesTransdermal Skin Patch Revenue Growth 2020-2025 ($ millions)
Figure 77. Manufacturing Cost Structure Analysis ofTransdermal Skin Patch in 2025
Figure 78. Manufacturing Process Analysis ofTransdermal Skin Patch
Figure 79. Industry Chain Structure ofTransdermal Skin Patch
Figure 80. Channels of Distribution
Figure 81. GlobalTransdermal Skin Patch Sales MarketForecast by Region (2026-2031)
Figure 82. GlobalTransdermal Skin Patch Revenue Market ShareForecast by Region (2026-2031)
Figure 83. GlobalTransdermal Skin Patch Sales Market ShareForecast byType (2026-2031)
Figure 84. GlobalTransdermal Skin Patch Revenue Market ShareForecast byType (2026-2031)
Figure 85. GlobalTransdermal Skin Patch Sales Market ShareForecast by Application (2026-2031)
Figure 86. GlobalTransdermal Skin Patch Revenue Market ShareForecast by Application (2026-2031)